Screening for hepatocellular carcinoma: What is missing?

Area of Science:

• Hepatology
• Oncology
• Viral Hepatitis Management

Background:

• Established guidelines exist for hepatocellular carcinoma (HCC) screening and management by major liver societies.
• Current practices reveal significant challenges and deficiencies in the actual implementation of HCC screening.
• Hepatitis C treatment advancements, while beneficial, present ongoing risks for HCC development, even post-cure.

Purpose of the Study:

• To critically evaluate the current diagnostic and screening practices for hepatocellular carcinoma (HCC).
• To highlight the discrepancies between recommended HCC screening guidelines and clinical reality.
• To emphasize the importance of timely and accurate screening for improving patient survival.

Main Methods:

• Review of existing literature and clinical guidelines on HCC diagnosis and screening.
• Analysis of current screening practices and their effectiveness.
• Discussion of challenges in HCC screening adherence.

Main Results:

• Despite guidelines, the practical application of HCC screening is suboptimal.
• Accurate diagnosis of cirrhosis and timely screening are critical for improved survival post-HCC diagnosis.
• Direct-acting antiviral therapy for hepatitis C may be associated with an increased risk of HCC in some cases.

Conclusions:

• There is a pressing need to improve physician adherence to current HCC screening recommendations.
• Enhancing the quality and timeliness of HCC screening is paramount for improving patient outcomes.
• Further research is needed to understand the evolving risks of HCC in the context of hepatitis C treatment.